Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Facial Aesthetic Treatment in Millennials
NCT04755595Phase 2Completed
- Sponsor
- SUNY Downstate Health Sciences University
- Start
- Mar 2021
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A, sponsored by SUNY Downstate Health Sciences University. Started Mar 2021; status: completed.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on NCT04755595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04755595.